drugset / Trial / NCT06207253

The Antimicrobial Potential of Diclofenac Sodium as an Intracanal Medicament

NCT06207253

Phase 2/3 Recruiting 48 enrolled British University In Egypt
RandomizedParallel-groupDouble-blindTreatment

Summary

The goal of this randomized clinical trial is to evaluate the capability of the material to exert bacterial reduction of diclofenac sodium versus of that calcium hydroxide paste when these materials are used as intracanal medications in permanent molar teeth with chronic apical periodontitis. The main question\[s\] it aims to answer are: • Will the diclofenac sodium (NSAIDs) possess antimicrobial efficacy to be used effectively as an intracanal medicament similar to that of calcium hydroxide in primary endodontic treatment? Participants will be allocated randomly into three equal groups by using computer generated randomization, according to the type of intracanal medication.

Timeline

Start
2025-11
Primary completion
2025-12
Completion
2025-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Calcium Hydroxide Other / unclassified
Subject Diclofenac Other / unclassified

Indications